237 research outputs found

    Fluvial dynamics and watermills location in Basilicata (Southern Italy)

    Get PDF
    Watermills (grain mills, waulk mills, olive mills, sawmills and threshing machines) operated in the Basilicata Region from the Roman Period until the early decades of the twentieth century, representing an important feature of waterways that is today almost totally forgotten. Using documentary sources, ancient maps and field survey it is possible to catalogue and identify the location of these ancient hydraulic structures. Watermills were usually placed far enough away from the river to avoid inundation during floods, and near natural knickpoints or artificial steps in the river long profile that were created by mill engineers. Mill construction often had significant impacts on a rivers morphology, because it was necessary to divert the river discharge towards the mill wheel, to drive the grain-grinding mechanism. Watermill typological variations have been examined in relation to variations in river pattern to assess the ways in which the hydrographic and hydrological settings of the Basilicata Region have affected mill siting and operation. Most Basilicata watermills were built with a horizontal water-wheel and a tower. The characteristics of the tower and the associated hydraulic structures varied according to the environmental setting. Finally, mill positions define also the locations on the river system that have already been used to exploit hydraulic power and thus could be useful for future use in the micro-hydroelectric secto

    Palombari, cisterne e pozzi per l’approvigionamento idrico nei Sassi di Matera (Basilicata) / Underground cisterns and wells for water supply in the Matera town (South Italy)

    Get PDF
    L'obiettivo della ricerca è avviare uno studio sulla tecnologia idraulica antica della città di Matera, di cui non si ha un’ aggiornata conoscenza, nonostante cisterne, pozzi e canali abbiano contribuito all'iscrizione della città nella Lista del Patrimonio Mondiale dell’UNESCO nel 1993. Cisterne e pozzi, tipici di molte civiltà rupestri del Mediterraneo, sono stati studiati attraverso fonti bibliografiche e d’archivio. Le strutture idrauliche sono risultate strettamente correlate alle caratteristiche idro-geomorfologiche dei luoghi e rappresentano l’esempio di una profonda conoscenza del territorio e della sua gestione virtuosa. La relazione tra l'approvvigionamento idrico e il paesaggio (studiato da un punto di vista geografico, idrogeologico e litologico) ha permesso una lettura integrata delle forme naturali e antropiche delle antiche reti idriche. / The aim of the present research is the knowledge of the ancient hydraulic systems for water supply at the Materan Sassi in the Basilicata region (Southern Italy), before the advent of modern aqueduct. An up-to-date knowledge on Materan ancient hydraulic technology is not available, despite underground cisterns, wells and canals contributed to the city's inscription on the World Heritage List in 1993). Cisterns and wells, typical of many Mediterranean rock civilizations, are an example of a deep knowledge of the territory and its potential and virtuous management. In fact, the hydraulic structures differ according to the hydro-geomorphological characteristics of the places For this reason, the relationship between water supply and landscape (studied from a geographic, hydrogeological and lithological point of view) will be analyzed, to promote an integrated reading of the natural and anthropogenic forms of water networks

    Mechanisms of altered bone remodeling in children with type 1 diabetes

    Get PDF
    Bone loss associated with type 1 diabetes mellitus (T1DM) begins at the onset of the disease, already in childhood, determining a lower bone mass peak and hence a greater risk of osteoporosis and fractures later in life. The mechanisms underlying diabetic bone fragility are not yet completely understood. Hyperglycemia and insulin deficiency can affect the bone cells functions, as well as the bone marrow fat, thus impairing the bone strength, geometry, and microarchitecture. Several factors, like insulin and growth hormone/insulin-like growth factor 1, can control bone marrow mesenchymal stem cell commitment, and the receptor activator of nuclear factor-kappa B ligand/osteoprotegerin and Wnt-b catenin pathways can impair bone turnover. Some myokines may have a key role in regulating metabolic control and improving bone mass in T1DM subjects. The aim of this review is to provide an overview of the current knowledge of the mechanisms underlying altered bone remodeling in children affected by T1DM

    Theatre is a valid add-on therapeutic intervention for emotional rehabilitation of parkinson's disease patients

    Get PDF
    Conventional medical treatments of Parkinson's disease (PD) are effective on motor disturbances but may have little impact on nonmotor symptoms, especially psychiatric ones. Thus, even when motor symptomatology improves, patients might experience deterioration in their quality of life. We have shown that 3 years of active theatre is a valid complementary intervention for PD as it significantly improves the well-being of patients in comparison to patients undergoing conventional physiotherapy. Our aim was to replicate these findings while improving the efficacy of the treatment. We ran a single-blinded pilot study lasting 15 months on 24 subjects with moderate idiopathic PD. 12 were assigned to a theatre program in which patients underwent "emotional" training. The other 12 underwent group physiotherapy. Patients were evaluated at the beginning and at the end of their treatments, using a battery of eight clinical and five neuropsychological scales. We found that the emotional theatre training improved the emotional well-being of patients, whereas physiotherapy did not. Interestingly, neither of the groups showed improvements in either motor symptoms or cognitive abilities tested by the neuropsychological battery. We confirmed that theatre therapy might be helpful in improving emotional well-being in PD

    Periodontal Disease: Linking the Primary Inflammation to Bone Loss

    Get PDF
    Periodontal disease (PD), or periodontitis, is defined as a bacterially induced disease of the tooth-supporting (periodontal) tissues. It is characterized by inflammation and bone loss; therefore understanding how they are linked would help to address the most efficacious therapeutic approach. Bacterial infection is the primary etiology but is not sufficient to induce the disease initiation or progression. Indeed, bacteria-derived factors stimulate a local inflammatory reaction and activation of the innate immune system. The innate response involves the recognition of microbial components by host cells, and this event is mediated by toll-like receptors (TLRs) expressed by resident cells and leukocytes. Activation of these cells leads to the release of proinflammatory cytokines and recruitment of phagocytes and lymphocytes. Activation of T and B cells initiates the adaptive immunity with Th1 Th2 Th17 Treg response and antibodies production respectively. In this inflammatory scenario, cytokines involved in bone regulation and maintenance have considerable relevance because tissue destruction is believed to be the consequence of host inflammatory response to the bacterial challenge. In the present review, we summarize host factors including cell populations, cytokines, and mechanisms involved in the destruction of the supporting tissues of the tooth and discuss treatment perspectives based on this knowledge

    High Sclerostin and Dickkopf-1 (DKK-1) serum levels in children and adolescents with type 1 diabetes mellitus

    Get PDF
    CONTEXT: Childhood type 1 diabetes (T1DM) is associated with decreased bone mass. Sclerostin and dickkopf-1 (DKK-1) are Wnt inhibitors which regulate bone formation. OBJECTIVE: To evaluate sclerostin and DKK-1 levels in TD1M children and to analyze the influence of the glycaemic control on bone health. DESIGN AND SETTING: Cross-sectional study conducted at a clinical research center. Partecipants: One hundred and six T1DM subjects (12.2 ± 4 years), 66 on multiple daily injections (MDI) and 40 on continuous subcutaneous infusion of insulin (CSII), and 80 controls. RESULTS: The average of bone transmission time (BTT) and amplitude-dependent speed of sound (Ad-Sos) Z-scores was lower in diabetics than controls. Significant increased DKK-1 (3593 ± 1172 vs 2652 ± 689 pg/ml, p<0.006) and sclerostin (29.45 ± 12.32 vs 22.53 ± 8.29, p<0.001) levels were found in diabetics respect to controls, particularly in patients on MDI than ones on CSII. Glycaemic control was improved in CSII patients compared to MDI ones (p<0.001) and was also associated to a significant higher BMI-SDS (p<0.002) and BTT-Z-score (p<0.02). With adjustment for age multiple linear regression analysis for DKK-1 and sclerostin as dependent variables showed that levels of HbA1c%, glucose, 25(OH)-Vitamin D, osteocalcin, PTH, years of diabetes, BMI-SDS and AD-SoS-Z-score are the most important predictors (p<0.0001). CONCLUSIONS: Our study highlighted: 1. the high serum levels of DKK-1 and sclerostin in T1DM children, and their relationship with the altered glycaemic control; 2. the effect of CSII on the improvement of glycaemic control and bone health in T1DM children

    Metabolic Bone Disease of Prematurity: Diagnosis and Management

    Get PDF
    Metabolic Bone Disease (MBD) of prematurity is a multifactorial disorder commonly observed in very low birth weight (VLBW, <1,500 g) newborns, with a greater incidence in those extremely low birth weight (ELBW, <1,000 g). MBD is characterized by biochemical and radiological findings related to bone demineralization. Several antenatal and postnatal risk factors have been associated to MBD of prematurity, although the main pathogenetic mechanism is represented by the reduced placental transfer of calcium and phosphate related to preterm birth. The diagnosis of MBD of prematurity requires the assessment of several biochemical markers, radiological, and ultrasonographic findings. However, the best approach is the prevention of the symptomatic disease, based on the screening of subjects exposed to the risks of developing MBD. Regarding the subjects who need to be screened, there is a substantial agreement on the potential risk factors for MBD. On the contrary, different recommendations exist on the diagnosis, management and treatment of this disorder of bone metabolism. This review was aimed at: (1) identifying the subjects at risk for MBD of prematurity; (2) indicating the biochemical findings to take in consideration for the prevention of MBD of prematurity; (3) suggesting practical recommendations on nutritional intake and supplementation in these subjects. We searched for papers which report the current recommendations for biochemical assessment of MBD of prematurity and for its prevention and treatment. The majority of the authors suggest that MBD of prematurity is a disease which tends to normalize overtime, thus it is not mandatory to mimic the rate of mineral fetal accretion through parenteral or enteral supplementation. The optimization of total parenteral nutrition (TPN) and the early achievement of a full enteral feeding are important goals for the prevention and management of MBD of prematurity

    New data on the genus Albinaria (Pulmonata: Clausiliidae) from the island of Astypalea and neighboring islets (Dodecanese Archipelago, Greece)

    Get PDF
    The highly diverse genus Albinaria Vest, 1867 (Pulmonata: Clausiliidae) is present in the Dodecanese archipelago with 12 species and 32 subspecies. Species identification is almost exclusively based on shell morphology and recent molecular studies have largely confirmed species classification based on shell morphology. In this communication A. brevicollis astropalia from the South-West of the island is redescribed and discussed in detail.peer-reviewe

    Impaired bone remodeling in children with osteogenesis imperfecta treated and untreated with bisphosphonates: the role of DKK1, RANKL, and TNF-α

    Get PDF
    In this study, we investigated the bone cell activity in patients with osteogenesis imperfecta (OI) treated and untreated with neridronate. We demonstrated the key role of Dickkopf-1 (DKK1), receptor activator of nuclear factor-κB ligand (RANKL), and tumor necrosis factor alpha (TNF-α) in regulating bone cell of untreated and treated OI subjects. These cytokines could represent new pharmacological targets for OI. Introduction: Bisphosphonates are widely used in the treatment of children with osteogenesis imperfecta (OI) with the objective of reducing the risk of fractures. Although bisphosphonates increase bone mineral density in OI subjects, the effects on fracture incidence are conflicting. The aim of this study was to investigate the mechanisms underlying bone cell activity in subjects with mild untreated forms of OI and in a group of subjects with severe OI treated with cycles of intravenous neridronate. Methods: Sclerostin, DKK1, TNF-α, RANKL, osteoprotegerin (OPG), and bone turnover markers were quantified in serum of 18 OI patients (12 females, mean age 8.86 ± 3.90), 8 of which were receiving cyclic intravenous neridronate, and 21 sex- and age-matched controls. The effects on osteoblastogenesis and OPG expression of media conditioned by the serum of OI patients and anti-DKK1 neutralizing antibody were evaluated. Osteoclastogenesis was assessed in cultures from patients and controls. Results: DKK1 and RANKL levels were significantly increased both in untreated and in treated OI subjects with respect to controls. The serum from patients with high DKK1 levels inhibited both osteoblast differentiation and OPG expression in vitro. High RANKL and low OPG messenger RNA (mRNA) levels were found in lymphomonocytes from patients. High amounts of TNF-α were expressed by monocytes, and an elevated percentage of circulating CD11b-CD51/CD61+ osteoclast precursors was observed in patients. Conclusions: Our study demonstrated the key role of DKK1, RANKL, and TNF-α in regulating bone cell activity of subjects with OI untreated and treated with bisphosphonates. These cytokines could represent new pharmacological targets for OI patients
    • …
    corecore